Index Performance
Overview
Description
The coming years will welcome a new breed of historically important, publicly listed healthcare technology companies that more closely resemble the tech mega-caps of today, with platform-based innovation, highly scalable business models, network effects, high impact, and high value creation. Technologies such as teleoperated devices, wearable sensors, and machine learning and artificial intelligence are arming patients and healthcare providers with tools to make better and quicker clinical decisions. The intersection of healthcare and technology has the potential to transform everything from how patients interact with care providers, to how diagnostic data is obtained and analyzed, from the ways interventions are recommended to the ways outcomes are measured. Developed by Lux Capital, the Lux Health + Tech Index™ recognizes the life-changing power of healthcare + technology.
Full methodology- TickerLUXHT
- Inception Date04/27/2021
- WeightingEqual
- # of holdings43
What's inside?
Holdings
All holdings as of April 22, 2025
GRAIL, Inc. (GRAL) | 5.76% | $1.05B | 34.90% | -62.12% | -0.72 |
Guardant Health, Inc. (GH) | 4.97% | $5.41B | 31.04% | 60.79% | 5.75 |
iRhythm Technologies, Inc. (IRTC) | 4.00% | $3.18B | 20.13% | 68.86% | 5.09 |
Schrödinger, Inc. (SDGR) | 3.75% | $1.90B | -4.21% | 63.64% | 5.55 |
Hims & Hers Health, Inc. (HIMS) | 3.62% | $5.63B | 69.33% | 78.30% | 3.68 |
Progyny, Inc. (PGNY) | 3.41% | $1.87B | 7.22% | 21.71% | 1.23 |
Waystar Holding Corp. (WAY) | 3.31% | $6.10B | 19.28% | 46.76% | 6.95 |
Adaptive Biotechnologies Corp. (ADPT) | 3.23% | $1.04B | 5.10% | 53.95% | 4.93 |
Doximity, Inc. (DOCS) | 3.01% | $9.83B | 24.63% | 91.59% | 18.11 |
Natera, Inc. (NTRA) | 2.81% | $19.55B | 56.75% | 60.30% | 11.17 |
Masimo Corp. (MASI) | 2.76% | $8.22B | 2.26% | 47.96% | 4.61 |
Insulet Corp. (PODD) | 2.68% | $17.14B | 22.07% | 70.48% | 9.54 |
Veeva Systems, Inc. (VEEV) | 2.66% | $35.11B | 16.20% | 74.03% | 12.19 |
Intuitive Surgical, Inc. (ISRG) | 2.51% | $171.52B | 17.24% | 67.46% | 22.17 |
Globus Medical, Inc. (GMED) | 2.50% | $11.21B | 60.62% | 54.16% | 4.39 |
DexCom, Inc. (DXCM) | 2.46% | $26.01B | 11.34% | 60.29% | 7.96 |
Veracyte, Inc. (VCYT) | 2.39% | $2.43B | 23.46% | 64.95% | 6.41 |
ResMed, Inc. (RMD) | 2.32% | $31.44B | 10.26% | 57.74% | 6.91 |
Fulgent Genetics, Inc. (FLGT) | 2.25% | $569.78M | -1.99% | 35.01% | 1.08 |
Lifestance Health Group, Inc. (LFST) | 2.24% | $2.36B | 18.50% | 26.50% | 2.50 |
Twist Bioscience Corp. (TWST) | 2.16% | $2.20B | 24.08% | 48.29% | 7.76 |
Clover Health Investments Corp. (CLOV) | 2.13% | $1.73B | -32.45% | N/A | 1.13 |
Tempus AI, Inc. (TEM) | 2.06% | $7.48B | 30.38% | 53.20% | 7.92 |
Teladoc Health, Inc. (TDOC) | 1.93% | $1.21B | -1.26% | 56.23% | 0.71 |
Castle Biosciences, Inc. (CSTL) | 1.90% | $634.01M | 51.09% | 77.94% | 1.54 |
Cytek Biosciences, Inc. (CTKB) | 1.89% | $484.85M | 3.85% | 55.43% | 2.98 |
Hologic, Inc. (HOLX) | 1.84% | $13.06B | 0.86% | 56.35% | 4.31 |
PROCEPT BioRobotics Corp. (PRCT) | 1.83% | $2.89B | 64.84% | 61.07% | 17.57 |
Align Technology, Inc. (ALGN) | 1.82% | $12.73B | 3.54% | 70.55% | 3.68 |
NeoGenomics, Inc. (NEO) | 1.77% | $1.25B | 11.65% | 38.85% | 3.49 |
Inspire Medical Systems, Inc. (INSP) | 1.76% | $4.43B | 28.49% | 84.68% | 6.54 |
Pacific Biosciences of California, Inc. (PACB) | 1.72% | $348.49M | -23.19% | 15.37% | 5.27 |
EXACT Sciences Corp. (EXAS) | 1.65% | $8.20B | 10.37% | 69.55% | 4.38 |
GoodRx Holdings, Inc. (GDRX) | 1.61% | $1.71B | 5.61% | 85.14% | 2.42 |
IQVIA Holdings, Inc. (IQV) | 1.59% | $25.32B | 2.95% | 27.66% | 3.16 |
Definitive Healthcare Corp. (DH) | 1.50% | $391.38M | 0.31% | 63.38% | 2.40 |
CareDx, Inc. (CDNA) | 1.47% | $985.20M | 19.07% | 66.40% | 2.94 |
Oscar Health, Inc. (OSCR) | 1.47% | $2.91B | 56.54% | N/A | 0.42 |
Illumina, Inc. (ILMN) | 1.33% | $11.77B | -2.93% | 65.46% | 5.18 |
Health Catalyst, Inc. (HCAT) | 1.20% | $256.97M | 3.60% | 32.74% | 1.42 |
10X Genomics, Inc. (TXG) | 1.02% | $982.53M | -1.28% | 70.09% | 2.32 |
Tandem Diabetes Care, Inc. (TNDM) | 1.00% | $1.09B | 25.74% | 50.51% | 2.54 |
Myriad Genetics, Inc. (MYGN) | 0.72% | $684.83M | 11.21% | 69.89% | 1.52 |